IT8848558A0 - Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento - Google Patents

Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento

Info

Publication number
IT8848558A0
IT8848558A0 IT8848558A IT4855888A IT8848558A0 IT 8848558 A0 IT8848558 A0 IT 8848558A0 IT 8848558 A IT8848558 A IT 8848558A IT 4855888 A IT4855888 A IT 4855888A IT 8848558 A0 IT8848558 A0 IT 8848558A0
Authority
IT
Italy
Prior art keywords
treatment
cataracts
carnitine
acetyl
pharmaceutical compositions
Prior art date
Application number
IT8848558A
Other languages
English (en)
Other versions
IT1235153B (it
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT8848558A priority Critical patent/IT1235153B/it
Publication of IT8848558A0 publication Critical patent/IT8848558A0/it
Priority to EP89830491A priority patent/EP0375628B1/en
Priority to ES89830491T priority patent/ES2062100T3/es
Priority to AT89830491T priority patent/ATE99172T1/de
Priority to DE89830491T priority patent/DE68911891T2/de
Priority to ZA898667A priority patent/ZA898667B/xx
Priority to US07/436,203 priority patent/US5037851A/en
Priority to JP1298729A priority patent/JPH02180820A/ja
Application granted granted Critical
Publication of IT1235153B publication Critical patent/IT1235153B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT8848558A 1988-11-15 1988-11-15 Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento IT1235153B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT8848558A IT1235153B (it) 1988-11-15 1988-11-15 Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
EP89830491A EP0375628B1 (en) 1988-11-15 1989-11-13 Use of acetyl L-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment
ES89830491T ES2062100T3 (es) 1988-11-15 1989-11-13 Empleo de acetil l-carnitina en el tratamiento terapeutico de cataratas y composiciones farmaceuticas utiles en este tratamiento.
AT89830491T ATE99172T1 (de) 1988-11-15 1989-11-13 Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.
DE89830491T DE68911891T2 (de) 1988-11-15 1989-11-13 Verwendung von Acetyl-L-carnitin zur Behandlung von Katarakt, sowie pharmazeutische Zusammensetzungen für eine derartige Behandlung.
ZA898667A ZA898667B (en) 1988-11-15 1989-11-14 Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment
US07/436,203 US5037851A (en) 1988-11-15 1989-11-14 Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment
JP1298729A JPH02180820A (ja) 1988-11-15 1989-11-15 アセチル―ｌ―カルニチン白内障処置剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848558A IT1235153B (it) 1988-11-15 1988-11-15 Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento

Publications (2)

Publication Number Publication Date
IT8848558A0 true IT8848558A0 (it) 1988-11-15
IT1235153B IT1235153B (it) 1992-06-22

Family

ID=11267312

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8848558A IT1235153B (it) 1988-11-15 1988-11-15 Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento

Country Status (8)

Country Link
US (1) US5037851A (it)
EP (1) EP0375628B1 (it)
JP (1) JPH02180820A (it)
AT (1) ATE99172T1 (it)
DE (1) DE68911891T2 (it)
ES (1) ES2062100T3 (it)
IT (1) IT1235153B (it)
ZA (1) ZA898667B (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
DK0951909T4 (da) 1998-03-19 2011-01-24 Sigma Tau Ind Farmaceuti Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
CA2338638C (en) * 1998-07-30 2009-03-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
DK1341813T3 (da) * 2000-12-15 2007-01-15 Sigma Tau Ind Farmaceuti Anvendelse af L-carnitin som stabiliseringsmiddel af proteiner
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
AU2006265248B2 (en) * 2005-07-01 2011-12-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye-drops
CA2611914C (en) 2005-07-08 2013-11-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid soluble benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
EP2363126A1 (en) 2010-03-04 2011-09-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
EP2642991A1 (en) 2010-11-22 2013-10-02 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutical method for the treatment of the leber optic
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2783695A1 (en) 2013-03-28 2014-10-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1184655B (it) * 1985-10-14 1987-10-28 Sigma Tau Ind Farmaceuti Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock

Also Published As

Publication number Publication date
US5037851A (en) 1991-08-06
DE68911891D1 (de) 1994-02-10
IT1235153B (it) 1992-06-22
ATE99172T1 (de) 1994-01-15
ES2062100T3 (es) 1994-12-16
DE68911891T2 (de) 1994-04-21
EP0375628A2 (en) 1990-06-27
EP0375628A3 (en) 1991-08-14
JPH02180820A (ja) 1990-07-13
ZA898667B (en) 1990-10-31
EP0375628B1 (en) 1993-12-29

Similar Documents

Publication Publication Date Title
IT1224795B (it) Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
IT8848558A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
FR2636532B1 (fr) Compositions pharmaceutiques
IT1236831B (it) Apparecchio per il trattamento dell'intestino in particolare per enteroclisma
LV10878A (lv) Adas apstradasana ar izveletiem amfifiliem kopolimeriem
DK489189A (da) Farmaceutisk praeparat
FI911179A7 (fi) Liikalihavuuden ja essentiaalisen verenpainetaudin sekä sukulaistautie n hoito
IT8867534A0 (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
DK295190D0 (da) Kosmetik- og hudbehandlingssammensaetninger
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
IT1239542B (it) Composizione farmaceutica comprendente piroxicam e procedimento per lasua preparazione
FI923033A7 (fi) N-fenyylitioureajohdannaisia ja niiden farmaseuttinen käyttö
DE69024843D1 (de) Rhodanin-Derivate und pharmazeutische Zusammensetzungen
IT1229491B (it) Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
FI905825A7 (fi) Amfifiiliset peptidit ja niiden käyttö
DK496889A (da) Peptidholdigt farmaceutisk praeparat
ITMI912509A0 (it) Uso della nimesulide nel trattamento della cataratta
DK336489A (da) Farmaceutisk praeparat
IT8948660A0 (it) Farmaco attivo nel ripristino della plasticita' neuronale
FI895286A7 (fi) Fenyylioksipropanoliamineja, niiden valmistus ja terapeuttinen käyttö
FI893366A7 (fi) 4-piperidyylimetyyli-2,3-dihydro-1H-isoindoli- ja 2,3,4,5-tetrahydro-1H-bentsatsepiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI901607A7 (fi) Lääkeaine ja sen käyttö parasitoosin käsittelyyn
DK429589A (da) Transdermalt laegemiddelpraeparat
FI890324A7 (fi) Substituoitujen dibentso- ja pyridobentsoatsepinonien aminoketonijohdannaisia ja farmaseuttisia kokoonpanoja

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19931014